Zoghbi Huda Y insider trades
Zoghbi Huda Y has filed 10 Form 4s with the SEC that we hold, all for Regeneron Pharmaceuticals, INC. (REGN), as Director. Across all of them we count 0 purchases worth $0 and 17 sales worth $5.8M reported on Form 4. In the last 12 months: 0 purchases ($0) and 12 sales ($1.9M). The largest single trade was a sale of 2,000 shares of Regeneron Pharmaceuticals, INC. worth $1.4M, dated 2022-03-16. The first filing on our record is dated 2021-09-15 and the latest 2026-08-12.
Regeneron Pharmaceuticals, INC. (REGN)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2021-09-13 | S, sale reported on Form 4 | 2 | $1.3K | 2021-09-15 |
| 2021-09-14 | S, sale reported on Form 4 | 998 | $648.7K | 2021-09-15 |
| 2022-03-16 | S, sale reported on Form 4 | 2,000 | $1.4M | 2022-03-18 |
| 2023-10-13 | S, sale reported on Form 4 | 1,000 | $850.0K | 2023-10-17 |
| 2024-01-02 | S, sale reported on Form 4 | 1,117 | $1.0M | 2024-01-04 |
| 2026-02-19 | S, sale reported on Form 4 | 4 | $3.2K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 160 | $125.5K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 56 | $44.0K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 49 | $38.0K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 220 | $172.3K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 298 | $233.1K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 209 | $163.3K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 331 | $258.3K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 208 | $162.1K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 53 | $41.3K | 2026-02-23 |
| 2026-02-19 | S, sale reported on Form 4 | 50 | $38.8K | 2026-02-23 |
| 2026-08-10 | S, sale reported on Form 4 | 800 | $640.0K | 2026-08-12 |
Counted from the Form 4 filings this reporting owner (SEC CIK 1681643) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms